16 June 2020
SpeeDx and Roche Partner to Expand Access to Antibiotic Resistance Tests
SpeeDx has partnered with Roche, a global pioneer in pharmaceuticals and diagnostics, to expand access to infectious disease and antibiotic...
4 May 2020
Mycoplasma genitalium more prevalent in women with bacterial vaginosis
Important data using ResistancePlus® MG to investigate over 1500 symptomatic vaginitis patients. Mycoplasma genitalium (Mgen) infection was more prevalent in...
17 April 2020
SpeeDx Blue Sky Research Team Publish Novel Research
SpeeDx is committed to continually improving and innovating diagnostics with ongoing advances spun out of our remarkable Blue Sky Research...
12 February 2020
SpeeDx Raise Additional $15 Million in Series B Funding
SpeeDx today announced it has raised $15 million in additional series B equity investment from U.S.-based Northpond Ventures. This investment...
16 January 2020
SpeeDx and LabCorp Working Together
SpeeDx and LabCorp are working together to develop and introduce new tests with the promise to help improve patient care,...
17 November 2019
Melbourne Sexual Health Continue Success with Resistance Guided Therapy
Mycoplasma genitalium (Mgen) infections treated using resistance guided therapy led to high cure rates and low levels of de novo...
